2557636|t|Multiple actions of THA on cholinergic neurotransmission in Alzheimer brains.
2557636|a|1,2,3,4-tetrahydro-9-aminoacridine (THA) is a cholinesterase inhibitor presently under investigation in clinical trials for treatment of Alzheimer's disease, senile dementia of Alzheimer type (AD/SDAT). To further analyse the underlying mechanisms for its effect in human brain, an in vitro model which allows measurement of acetylcholine (ACh) release from human postmortem brain slices has been used. In control cortical tissue THA induces a decreased release of ACh probably due to negative feedback mechanisms mediated via presynaptic muscarinic autoreceptors. In AD/SDAT cortex THA enhances the release of ACh to control level. This effect is prevented by nicotinic or muscarinic receptor antagonists, which suggest receptor mechanisms involving both nicotinic and muscarinic receptors. Subchronic treatment of rats with THA (10 mg/kg sc twice daily) or physostigmine (0.9 mg/kg sc five times daily) causes a significant increase in the number of high affinity nicotinic receptors in the cortex of THA treated rats whereas no change is found in the physostigmine treated rats. The number of muscarinic receptors are decreased following both THA and physostigmine treatment.
2557636	20	23	THA	Chemical	MESH:D013619
2557636	60	69	Alzheimer	Disease	MESH:D000544
2557636	78	112	1,2,3,4-tetrahydro-9-aminoacridine	Chemical	MESH:D013619
2557636	114	117	THA	Chemical	MESH:D013619
2557636	124	138	cholinesterase	Gene	590
2557636	215	234	Alzheimer's disease	Disease	MESH:D000544
2557636	236	269	senile dementia of Alzheimer type	Disease	MESH:D000544
2557636	271	273	AD	Disease	MESH:D000544
2557636	274	278	SDAT	Disease	
2557636	344	349	human	Species	9606
2557636	403	416	acetylcholine	Chemical	MESH:D000109
2557636	418	421	ACh	Chemical	MESH:D000109
2557636	436	441	human	Species	9606
2557636	508	511	THA	Chemical	MESH:D013619
2557636	543	546	ACh	Chemical	MESH:D000109
2557636	646	648	AD	Disease	MESH:D000544
2557636	649	653	SDAT	Disease	
2557636	661	664	THA	Chemical	MESH:D013619
2557636	689	692	ACh	Chemical	MESH:D000109
2557636	739	783	nicotinic or muscarinic receptor antagonists	Chemical	-
2557636	894	898	rats	Species	10116
2557636	904	907	THA	Chemical	MESH:D013619
2557636	937	950	physostigmine	Chemical	MESH:D010830
2557636	1081	1084	THA	Chemical	MESH:D013619
2557636	1093	1097	rats	Species	10116
2557636	1132	1145	physostigmine	Chemical	MESH:D010830
2557636	1154	1158	rats	Species	10116
2557636	1224	1227	THA	Chemical	MESH:D013619
2557636	1232	1245	physostigmine	Chemical	MESH:D010830
2557636	Negative_Correlation	MESH:D013619	590
2557636	Negative_Correlation	MESH:D013619	MESH:D000544
2557636	Positive_Correlation	MESH:D000109	MESH:D013619
2557636	Cotreatment	MESH:D010830	MESH:D013619
2557636	Association	MESH:D000109	MESH:D000544

